ANCA-associated vasculitis therapy (IMC Biotechnology)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameANCA-associated vasculitis therapy (IMC Biotechnology)
Drug Alias Nameantineutrophil cytoplasmic antibody-associated vasculitis therapy (IMC Biotechnology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVasculitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIMC Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIMC Biotechnology
Active IndicationsN/A
Inactive IndicationsVasculitis

Other Information

ATC CodeN/A
Related LinksN/A